# Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease

> **NCT07235891** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Alexandria University** · enrollment: 40 (estimated)

## Conditions studied

- Retinal Nerve Fiber Layer Thickness
- Chronic Kidney Disease

## Interventions

- **DRUG:** Finerenone

## Key facts

- **NCT ID:** NCT07235891
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2026-12-20
- **Final completion:** 2027-03-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07235891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07235891, "Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07235891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*